Beta blockers could benefit patients with HFPEF
2014-11-16
(Press-News.org) A novel registry study from Karolinska Institutet in Sweden suggests that beta blockers may benefit also patients suffering from a relatively unknown form of heart failure called HFPEF, which today lacks well-established treatment. HFPEF involves an impaired ability of the heart to fill with blood, and affects nearly 2% of the population. These new findings are being published in the scientific periodical JAMA.
Heart failure was for a long time defined as reduced ability to contract the heart and pump oxygenated blood out to the rest of the body. This condition is often caused by long-standing high blood pressure or a previous heart attack. Men are affected more often than women, and there are several treatments improving symptoms and survival.
However, in recent years it has become clear that a new type of heart failure is equally common and serious. This type of heart failure, called HFPEF or heart failure with preserved ejection fraction, involves a reduced ability in the heart to relax and fill with blood. HFPEF is more common at old age and affects women more often than men. Until recently, there was no treatment against this disorder.
In the current study, a Swedish team comprising researchers from Karolinska Institutet, Linköping University, Stockholm South General Hospital, Danderyd Hospital and Karolinska University Hospital analysed data from 42,000 patients from the nation-wide Swedish Heart Failure Registry. According to the findings, patients with HFPEF who were treated with beta blockers had better survival than untreated patients. The difference persisted after adjustment for a large number of other factors, such as patient age, general health, socioeconomic and other factors, and the final decrease in mortality was 7% in the group treated with beta blockers.
In heart failure, stress hormones such as adrenaline are secreted and damage the heart in the long-term. Beta blockers protects against this damaging effect. In randomized trials in patients with reduced ability to contract the heart, beta blockers have been shown to reduce mortality. However, this is the first comprehensive study regarding the effect of beta blockers in patients with HFPEF.
In a previous study, the Swedish team also reported that HFPEF patients could benefit from other similar heart drugs, such as ACE-inhibitors and angiotensin receptor blockers. Researchers now plan to proceed with randomized clinical trials.
"This study was large and rigorous, but still cannot prove that beta blockers are beneficial in HFPEF", says Principal Investigator Lars H. Lund, Associate Professor at Karolinska Institutet. "However, it provides a rationale for performing large-scale randomized trials with this inexpensive category of drugs, which we now plan to go through with. Sweden has unique capabilities to implement such randomized studies in the context of the major Swedish quality registries."
INFORMATION:
The work was financed by the Swedish Research Council, The Swedish Heart-Lung Foundation, the Stockholm County Council and the Swedish Association of Local Authorities and Regions.
Publication: 'Association between Use of Beta-Blockers and Mortality in Patients with Heart Failure and Preserved Ejection Fraction', Lars H. Lund, Lina Benson, Ulf Dahlström, Magnus Edner, Leif Friberg, JAMA, online 16th November 2014. .
About the Swedish Heart Failure Registry: http://www.ucr.uu.se/rikssvikt-en
Contact the Press Office and download images: ki.se/pressroom
Karolinska Institutet - a medical university: ki.se/english
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2014-11-16
More than 40 percent of reports about energy drinks to U.S. poison control centers involved children younger than 6 with some suffering serious cardiac and neurological symptoms, according to a new study presented at the American Heart Association's Scientific Sessions 2014.
This disproportionate representation of children is concerning given the number of reports of serious cardiac and neurological symptoms, said Steven Lipshultz, M.D., the study's senior author and professor and chair of pediatrics at Wayne State University and pediatrician-in-chief at Children's Hospital ...
2014-11-16
Recent asthma symptoms or asthma that requires daily medication may significantly raise the risk of heart attack, according to two research papers presented at the American Heart Association's Scientific Sessions 2014.
"Physicians should do all they can to control every other modifiable cardiovascular risk factor in patients with asthma," said Matthew C. Tattersall, D.O., M.S., study author and an assistant professor of medicine in the Division of Cardiology at the University of Wisconsin-Madison School of Medicine and Public Health in Madison, Wisconsin.
Tattersall's ...
2014-11-16
Young women with stable coronary heart disease are more likely than men to have reduced blood flow to the heart if they're under emotional stress, but not physical stress, according to research presented at the American Heart Association's Scientific Sessions 2014.
Compared to men of the same age, when subjected to a mental stress test, women:
age 55 and younger had three times greater reduction in blood flow to the heart;
age 56-64 had double the reduction in blood flow to the heart; and
age 65 and older had no difference in blood flow to the heart.
"Women who ...
2014-11-16
Breathing secondhand marijuana smoke could damage your heart and blood vessels as much as secondhand cigarette smoke, according to preliminary research presented at the American Heart Association's Scientific Sessions 2014.
In the study, blood vessel function in lab rats dropped 70 percent after 30 minutes of exposure to secondhand marijuana smoke. Even when the marijuana contained no tetrahydrocannabinol (THC) -- a compound in marijuana that produces intoxication -- blood vessel function was still impaired.
Reduced blood vessel function may raise the chances of developing ...
2014-11-16
CHICAGO -- Patients with active asthma -- such as any use of asthma medications, and unscheduled office or emergency visits for asthma -- are at a twofold risk of having a heart attack, according to Mayo Clinic research presented at the American Heart Association's Scientific Sessions 2014.
Researchers compared 543 patients who had heart attacks with 543 non-heart attack patients of the same age and gender. These patients were treated at health care facilities in Rochester, Minnesota, between 2002 and 2006. The average age of patients was 67 years old, and 44 percent ...
2014-11-16
CHICAGO - Members of the public in counties with higher median household incomes are more likely to step into action to perform cardiopulmonary resuscitation, or CPR, when they witness someone have a cardiac arrest, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania, which was presented today at the American Heart Association's Resuscitation Science Symposium 2014.
"It's important for bystanders to act quickly when they witness someone experiencing cardiac arrest," said lead study author Kam Ching (Nina) Li, ...
2014-11-16
WASHINGTON -- Neuroscientists at Georgetown University Medical Center (GUMC) are zeroing in on brain factors and behaviors that put teens at risk of alcohol use and abuse even before they start drinking.
Four abstracts from the Adolescent Development Study exploring these factors will be presented at Neuroscience 2014, the Society for Neuroscience's annual meeting in Washington. The Adolescent Development Study, a collaboration between the University of Maryland School of Medicine (UMSOM) and GUMC funded by the National Institutes of Health (NIH), is a wide-ranging effort ...
2014-11-16
MIAMI -- A chemotherapy regimen consisting of procarbazine, CCNU, and vincristine (PCV) administered following radiation therapy improved progression-free survival and overall survival in adults with low-grade gliomas, a form of brain cancer, when compared to radiation therapy alone. The findings were part of the results of a Phase III clinical trial presented today at the Society for Neuro-Oncology's 19th Annual Meeting in Miami by the study's primary author Jan Buckner, M.D., deputy director, practice, at Mayo Clinic Cancer Center.
"On average, patients who received ...
2014-11-15
Philadelphia, PA (November 15, 2014) -- A healthy diet may help protect the kidneys, according to two studies that will be presented at ASN Kidney Week 2014 November 11¬-16 at the Pennsylvania Convention Center in Philadelphia, PA.
Dietary modifications may be a low-cost, simple intervention to reduce the burden of chronic kidney disease (CKD). To test this hypothesis, Andrew Smyth, MD (National University of Ireland Galway) and his colleagues analyzed questionnaires completed by 544,635 participants of the National Institutes of Health-AARP Diet and Health Study ...
2014-11-15
Boston -- A molecule in the blood shows promise as a marker to predict whether individual rheumatoid arthritis patients are likely to benefit from biologic medications or other drugs should be tried, a Mayo Clinic-led study shows. The protein, analyzed in blood tests, may help avoid trial and error with medications, sparing patients treatment delays and unnecessary side effects and expense. The research is among several Mayo Clinic studies presented at the American College of Rheumatology annual meeting in Boston.
Researchers tested blood samples taken before rheumatoid ...
LAST 30 PRESS RELEASES:
[Press-News.org] Beta blockers could benefit patients with HFPEF
